Stocktoria
JRSIS HEALTH CARE Corp JRSS
OTC · stock · Services-Hospitals · website · IPO 2014-03-06
JRSIS HEALTH CARE Corp financials (annual)
Bars are annual figures from 2014 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5M | $1.7M | $44.4M | $35.7M | $31.5M | $28.4M | $24.1M | $18.1M | $11.9M | $6.0M |
| Gross profit | $483,051 | $26,211 | — | — | — | — | — | — | — | — |
| R&D expense | $189,266 | $283,043 | — | — | — | — | — | — | — | — |
| Operating income | -$188,598 | -$684,776 | -$103,801 | $5.6M | $4.7M | $6.0M | $6.7M | $5.0M | $2.6M | $917,963 |
| Interest expense | $56,443 | $64,709 | $1.4M | $1.1M | $1.1M | $1.1M | $1.3M | $1.4M | $1.2M | $1.0M |
| Income tax | $8,975 | — | $1.2M | $1.4M | $657,699 | $2.8M | $2,528 | $4,059 | $2,604 | $2,157 |
| Net income | -$80,912 | -$575,839 | $3.2M | $3.8M | $888,061 | $2.0M | $4.6M | $3.5M | $1.8M | $611,494 |
| EPS (diluted) | $-0.00 | $-0.01 | $0.17 | $0.15 | $0.05 | $0.13 | — | — | — | $0.05 |
| Operating cash flow | $516,724 | -$1.8M | $8.2M | $10.6M | $11.8M | $9.2M | $8.3M | $5.0M | $2.5M | $2.1M |
| Free cash flow | $515,240 | -$1.8M | $5.9M | $2.4M | $7.1M | $5.9M | $5.7M | $1.5M | -$2.6M | -$1.5M |
| Cash & equivalents | — | $58,616 | $29,847 | $844,827 | $2.0M | $256,450 | $884,292 | $890,662 | $352,153 | $1.0M |
| Inventory | $455,240 | $562,015 | $1.8M | $1.5M | $1.1M | $1.2M | $936,549 | $801,240 | $499,080 | $180,630 |
| Total assets | $2.1M | $2.0M | $75.7M | $58.8M | $51.6M | $52.5M | $48.7M | $31.7M | $27.7M | $23.9M |
| Total liabilities | $2.3M | $2.1M | $42.6M | $30.0M | $28.6M | $30.4M | $28.4M | $20.0M | $20.3M | $18.9M |
| Shareholders' equity | -$160,652 | -$68,343 | $33.1M | $28.8M | $23.0M | $22.0M | $20.2M | $11.7M | $7.4M | $5.0M |
Growth · year-over-year · Revenue CAGR -5.9%
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +101.4% | -96.1% | +24.3% | +13.5% | +10.8% | +17.6% | +33.3% | +52.6% | +98.5% | +37.4% |
| Net income growth | — | -118.1% | -16.7% | +331.0% | -55.4% | -57.1% | +33.8% | +93.9% | +192.8% | +52.9% |
| EPS growth | — | -105.3% | +16.6% | +177.1% | -60.3% | — | — | — | — | -84.4% |
| Free cash flow growth | — | -130.5% | +150.0% | -66.8% | +20.5% | +3.0% | +280.4% | — | — | -627.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.